Physician consultation rates and characteristics among workers with chronic pain or headache who participated in a behavioural change program: a retrospective database analysis using real-world healthcare data
- PMID: 36356992
- PMCID: PMC9660713
- DOI: 10.1136/bmjopen-2021-056846
Physician consultation rates and characteristics among workers with chronic pain or headache who participated in a behavioural change program: a retrospective database analysis using real-world healthcare data
Abstract
Objective: To assess the potential benefit of a behavioural change programme in working individuals with chronic pain or headache, in the form of increased physician consultation.
Design: Retrospective observational database study.
Setting: Members of employment-based healthcare insurance in Japan.
Participants: Individual-level data of working individuals aged <75 years from November 2019 through March 2020 were extracted from a database managed by MinaCare Co., Ltd. Included individuals had records of programme participation and chronic pain or headache (self-reported), and did not consult physicians for ≥3 months before programme participation.
Outcome measures: Physician consultation rates after participating in the programme were examined from December 2019 through March 2020, separately for chronic pain and headache. Baseline characteristics included age, pain numeric rating scale (NRS) score (for chronic pain), suspected migraine (for headache), labour productivity including absenteeism and presenteeism, and 4-month indirect costs in Japanese yen (JPY).
Results: The baseline mean age (±SD) of 506 individuals with chronic pain was 46.8±10.1 years; that of 352 individuals with headache was 43.6±9.9 years. Of those with chronic pain, 71.4% had an NRS score≥4, and 49.7% of those with headache had suspected migraine. Overall, 11.3% and 5.4% of those with chronic pain or headache consulted physicians, respectively. The mean baseline absenteeism and presenteeism were 1.5% and 19.1% in those with chronic pain, and 1.5% and 23.0% in those with headache. The baseline indirect costs were 586 941.6 JPY and 1 060 281.6 JPY among those with chronic pain or headache, respectively.
Conclusion: Given that the individuals did not regularly consult physicians before the programme despite reporting substantial symptoms, our results suggest the potential benefit of educational programmes encouraging physician consultation. Further studies are required to evaluate how to effectively implement such educational programmes via healthcare insurers to reduce the burden of pain symptoms and overall medical costs.
Keywords: Back pain; Migraine; Musculoskeletal disorders; Pain management.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: KN, SM, SH and YA are employees of Viatris Pharmaceuticals Japan Inc.
Figures


Similar articles
-
Impact of pharmacist interventions on seeking of medical care by migraineurs.J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):32-7; quiz 1-4. doi: 10.1331/JAPhA.2008.07002. J Am Pharm Assoc (2003). 2008. PMID: 18192128
-
Medical consultation for migraine: results from the American Migraine Study.Headache. 1998 Feb;38(2):87-96. doi: 10.1046/j.1526-4610.1998.3802087.x. Headache. 1998. PMID: 9529763
-
Headache Education Active-Waiting Directive: A Program to Enhance Well-Being During Long Referral Wait Times.Headache. 2018 Jan;58(1):109-117. doi: 10.1111/head.13194. Epub 2017 Nov 12. Headache. 2018. PMID: 29131328
-
Improving care through health economics analyses: cost of illness and headache.J Headache Pain. 2008 Aug;9(4):199-206. doi: 10.1007/s10194-008-0051-9. Epub 2008 Jul 5. J Headache Pain. 2008. PMID: 18604472 Free PMC article. Review.
-
Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.Pain Pract. 2015 Sep;15(7):688-92. doi: 10.1111/papr.12243. Epub 2014 Oct 1. Pain Pract. 2015. PMID: 25271173 Review.
Cited by
-
Quantitative and Qualitative Pain Evaluation in Response to OnabotulinumtoxinA for Chronic Migraine: An Observational Real-Life Study.Toxins (Basel). 2023 Apr 15;15(4):284. doi: 10.3390/toxins15040284. Toxins (Basel). 2023. PMID: 37104222 Free PMC article.
References
-
- Ogawa S, lseki M. Kikuchi S. a large-scale survey on chronic pain and neuropathic pain in Japan. Clinical Orthopaedic Surgery 2012;47:565–74.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical